Back
Kairous Acquisition Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
47
KACL
Kairous Acquisition
Last Price:
12.29
Seasonality Move:
2.42%
Sell
50
DRUG
Bright Minds Biosciences
Last Price:
57.79
Seasonality Move:
-16.97%
Sell
47
Kairous Acquisition (KACL)
is a Sell
Is Kairous Acquisition a Buy, Sell or Hold?
- The current Kairous Acquisition [KACL] share price is $12.32. The Score for KACL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KACL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $28.80. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KACL Stock Price Chart
What is Kairous Acquisition's stock price today?
-
The Kairous Acquisition share price today is $12.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KACL is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $28.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
KACL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 59.12 | Buy |
Chaikin Money Flow: | 2701 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.18 - 12.28) | Buy |
Bollinger Bands (100): | (12.01 - 12.21) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.5 | Buy |
Relative Strength Index (14 RSI): | 77.84 | Buy |
Chaikin Money Flow: | 92732 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-4.96 - 12.54) | Buy |
Bollinger Bands (100): | (-2.76 - 6.3) | Buy |
KACL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.24 | Buy |
20-day SMA: | 12.23 | Buy |
50-day SMA: | 12.2 | Buy |
200-day SMA: | 11.91 | Buy |
8-day EMA: | 12.27 | Buy |
20-day EMA: | 12.24 | Buy |
50-day EMA: | 12.19 | Buy |
200-day EMA: | 11.89 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.28 | Buy |
20-day SMA: | 4.42 | Buy |
50-day SMA: | 2.44 | Buy |
200-day SMA: | 1.64 | Buy |
8-day EMA: | 13.74 | Buy |
20-day EMA: | 7.01 | Buy |
50-day EMA: | 3.65 | Buy |
200-day EMA: | 2.03 | Buy |
Kairous Acquisition Earnings Growth & KACL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kairous Acquisition Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |